Former senior exec of ArthroCare pleads guilty in $400 million securities fraud scheme
Helicos seeks bankruptcy court approval to license IP to Illumina, Life Tech, & Fluidigm (deals would be worth $3.5M)
Epicept announces earnings; merger with Immune Pharmaceuticals to be complete in Q3.
Submit an article to cafepharma's CP Wire. Click here to find out more.
Company |
Average | Last 24h | Increase |
|---|---|---|---|
| AGA Medical | 11 | 23 | 109 % |
| Apeiron | 1 | 3 | 200 % |
| Arena Pharmaceuticals | 3 | 9 | 200 % |
| Ariad Pharmaceuticals | 5 | 8 | 60 % |
| Astra Tech | 12 | 30 | 150 % |
| Aurobindo | 4 | 9 | 125 % |
| Aveo Pharmaceutical | 3 | 8 | 167 % |
| Becton Dickinson | 2 | 5 | 150 % |
| Bracco | 3 | 5 | 67 % |
| Braun | 39 | 60 | 54 % |
|
Company |
Average | Last 24 hrs | Increase |
|---|---|---|---|
| Abbott Laboratories | 17 | 51 | 200 % |
| Access Pharmaceuticals | 2 | 5 | 150 % |
| Acorda Therapeutics | 8 | 18 | 125 % |
| Affymetrix | 4 | 16 | 300 % |
| AGA Medical | 6 | 17 | 183 % |
| AkaRx | 1 | 2 | 100 % |
| Amerinet | 6 | 25 | 317 % |
| AP Pharma | 2 | 5 | 150 % |
| Ariad Pharmaceuticals | 1 | 2 | 100 % |
| Astra Tech | 2 | 3 | 50 % |